English
Deutsch
Switzerland (Group)
Ypsomed Websites
Switzerland (Group)
Australia
Austria
Belgium
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Italy
Niederlands
Norway
Poland
Spain
Sweden
United Kingdom
Keywords
Search
Skip navigation
Company
Vision - Mission
Corporate Strategy
Innovation & Digital Health
Access & Expansion
Responsibility & Engagement
Platforms & Operational Excellence
Group structure
Management team
Employees
YpsoStories
History
Suppliers
Contact
Subsidiaries and Distributors
Delivery Systems
Diabetes Care
Careers
ICT
Engineers
Quality & Regulatory
Manufacturing
Young professionals
Apprenticeship
Training conditions at Ypsomed
Working for Ypsomed
Career and continuing professional development
Programmes for employee development
Human Resources Policy
Quality of life
Working conditions and benefits
Living in the regions of our sites
Vacant Positions
Professionals
Apprenticeships
For recruitment agencies
Media & Investors
Facts & Figures
Press releases
Mailing list
Image gallery
Ad hoc announcement pursuant to Art. 53 LR
Financial calendar
Annual General Meeting
Reports
Presentations
Shares
Financial analysts coverage
Share key data
Dividend
Corporate Governance
Code of Conduct
Our investment in research and development is above average.
Investor and Analysts‘ conference for 2023/24 full-year results
05/22/2024
Zurich
Go Back
TOP
